Wei Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Top Venues

Journal of medicinal chemistry

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cunbo Ma, Di Kang, Panliang Gao, Wei Zhang, Xinping Wu, Zilong Xu, Huifeng Han, Lei Zhang, Yang Cai, Yanping Wang, Yinxiang Wang, Wei Long
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment. Journal of medicinal chemistry 67 (16) (2024)
Cunbo Ma, Di Kang, Panliang Gao, Wei Zhang, Xinping Wu, Zilong Xu, Huifeng Han, Lei Zhang, Yang Cai, Yanping Wang, Yinxiang Wang, Wei Long
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment. Journal of medicinal chemistry 67 (16) (2024)
Cunbo Ma, Di Kang, Panliang Gao, Wei Zhang, Xinping Wu, Zilong Xu, Huifeng Han, Lei Zhang, Yang Cai, Yanping Wang, Yinxiang Wang, Wei Long
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment. Journal of medicinal chemistry (2024)
Dapeng Ju, Wei Zhang, Jiawei Yan, Haijiao Zhao, Wei Li, Jiawen Wang, Meimei Liao, Zhancong Xu, Zhiqiang Wang, Guanshen Zhou, Long Mei, Nannan Hou, Shuhua Ying, Tao Cai, She Chen, Xiaowen Xie, Luhua Lai, Chao Tang, Noheon Park, Joseph S Takahashi, Niu Huang, Xiangbing Qi, Eric Erquan Zhang
Chemical perturbations reveal that RUVBL2 regulates the circadian phase in mammals. Science translational medicine 12 (542) (2021)